Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Xenon Pharmaceuticals Inc (NASDAQ: XENE) was $41.85 for the day, up 0.46% from the previous closing price of $41.66. In other words, the price has increased by $0.46 from its previous closing price. On the day, 0.53 million shares were traded. XENE stock price reached its highest trading level at $42.655 during the session, while it also had its lowest trading level at $41.66.
Ratios:
Our analysis of XENE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 23.27 and its Current Ratio is at 23.27. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On October 01, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $53.
On January 04, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $62.Citigroup initiated its Buy rating on January 04, 2024, with a $62 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 08 ’24 when GAROFALO ELIZABETH A. sold 2,092 shares for $45.69 per share. The transaction valued at 95,583 led to the insider holds 0 shares of the business.
ROBIN SHERRINGTON sold 7,137 shares of XENE for $330,290 on Mar 07 ’24. The EVP, Strategy & Innovation now owns 8,398 shares after completing the transaction at $46.28 per share. On Mar 07 ’24, another insider, GANNON STEVEN, who serves as the Director of the company, sold 13,000 shares for $46.28 each. As a result, the insider received 601,615 and left with 2,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XENE now has a Market Capitalization of 3170744064 and an Enterprise Value of 2459242496.
Stock Price History:
Over the past 52 weeks, XENE has reached a high of $50.99, while it has fallen to a 52-week low of $27.99. The 50-Day Moving Average of the stock is 3.90%, while the 200-Day Moving Average is calculated to be -0.08%.
Shares Statistics:
XENE traded an average of 344.66K shares per day over the past three months and 364120 shares per day over the past ten days. A total of 75.37M shares are outstanding, with a floating share count of 73.82M. Insiders hold about 2.56% of the company’s shares, while institutions hold 96.60% stake in the company. Shares short for XENE as of 1727654400 were 3301156 with a Short Ratio of 9.58, compared to 1724976000 on 3569456. Therefore, it implies a Short% of Shares Outstanding of 3301156 and a Short% of Float of 4.3899998.
